Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2022-10-01
2024-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
During this study approximately 30 healthy subjects will be recruited (10 from each center) from the staff and students at each center. These subjects are own staff and students of the 3 centers. Each subject will undergo a 3D gait analysis at each center (at UZGent, UHasselt and UMaastricht). Therefore, each subject will be evaluated 3 times. The time between each evaluations will be a maximum of one week.
The evaluations will be performed as per standard procedure in each lab. However, a standardized model (HBM2 lower limb), an agreed walking velocity (0.9 m/s, 1.0 m/s, 1.1 m/s) and an agreed duration per recording (3 min) will be used. The same software will be used to process the collected data. 3D kinematics and kinetic time-series data of the lower limbs will be extracted as outcome data. Absolute reliability indices will be calculated in the following way: First, the standard deviation (SD) of time-series data across different gait cycles will be calculated per participant per center. The SD values across different centers per participant will then be averaged. Finally, the SD values across different participants will form the inter-laboratory reliability indices. In addition, we will use statistical parametric mapping (Anova repeated measures) to compare the full time-series data of each outcome parameter.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Normative Database for Gait Analysis on the GRAIL UZ Gent
NCT04987346
Training and Testing Database for IMU Based Gait Analysis Methods
NCT07236008
Feasibility of Wearable Sensors to Determine Gait Parameters
NCT01620021
Assessment of Accelerometric Measurement Devices for Gait Analysis
NCT01522690
Comparison of Dual-Task Timed Up and Go Test (Cognitive) and 3-m Backwards Walk Test
NCT05211349
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy adults UZ Gent
A group of 30 healthy adults aged 18-65years old will carry out a 3D gait analysis at UZ Gent within a week of the 3D gait analysis at UHasselt and/or UMaastricht.
3D gait analysis on the GRAIL
3D gait anlysis performed on an instrumented treadmill (GRAIL, Motek Medical)
Weight and height
The subject's body weight and height will be assessed
Healthy adults UHasselt
The same group of 30 healthy adults aged 18-65years old will carry out a 3D gait analysis at UHasset within a week of the 3D gait analysis at UZGent and/or UMaastricht.
3D gait analysis on the GRAIL
3D gait anlysis performed on an instrumented treadmill (GRAIL, Motek Medical)
Weight and height
The subject's body weight and height will be assessed
Healthy adults UMaastricht
The same group of 30 healthy adults aged 18-65years old will carry out a 3D gait analysis at UHasset within a week of the 3D gait analysis at UZGent and/or UZGent.
3D gait analysis on the GRAIL
3D gait anlysis performed on an instrumented treadmill (GRAIL, Motek Medical)
Weight and height
The subject's body weight and height will be assessed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
3D gait analysis on the GRAIL
3D gait anlysis performed on an instrumented treadmill (GRAIL, Motek Medical)
Weight and height
The subject's body weight and height will be assessed
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* They suffer from a neurological disorder.
* They experience balance problems.
* They have had surgical procedures on the legs in the past.
* They are taking medication that may affect gait and balance. They experience leg or back pain at the time of test taking.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hasselt University
OTHER
Maastricht University
OTHER
University Ghent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lynn Bar-On, PhD
Role: PRINCIPAL_INVESTIGATOR
UGent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hasselt
Hasselt, , Belgium
Maastricht University
Maastricht, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ONZ-2022-0248
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.